177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice. (Q33961370)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

based on heuristic

inferred from title

Øyvind Sverre Bruland

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

Pål Kristian Selbo

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Ada H V Repetto-Llamazares

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

Roy H Larsen

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

Anna Maria Giusti

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

Elena Riccardi

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

Jostein Dahle

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

0 references

publication date

28 July 2014

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

e103070

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

copyright license

Creative Commons Attribution 4.0 International

28 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Biodistribution and dosimetry of (177)Lu-tetulomab, a new radioimmunoconjugate for treatment of non-Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Biodistribution and dosimetry of 177Lu-labeled [DOTA0,Tyr3]octreotate in male nude mice with human small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

The SCID mouse mutant: definition and potential use as a model for immune and hematological disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Imaging and treatment of B-cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Biological considerations for radioimmunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

5 July 2018

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0103070

21 January 2018

Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu(n,gamma)177Lu

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0103070

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4113375

29 October 2018

The scid mutation in mice causes a general defect in DNA repair

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0103070

21 January 2018

Hyperplastic and early neoplastic changes in the ovaries of mice after genic deletion of germ cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of two murine monoclonal antibodies reactive with human B cells. Their use in a high-yield, high-purity method for isolation of B cells and utilization of such cells in an assay for B-cell stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retention of B-cell-specific monoclonal antibodies by human lymphoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral microdistribution of [131I]MB-1 in patients with B-cell lymphoma following radioimmunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25068508

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0103070

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

2014PLoSO...9j3070R

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25068508 AND SRC:MED&resulttype=core&format=json

10 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33961370&oldid=2249122003"